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Abstract  
Introduction: Nasopharyngeal cancer is the most common type of head and neck cancer 
with prevalence of 6.2/100000 population. Recently, study of prognostic factors for 
nasopharyngeal cancer still becomes one of research focuses. Several studies have tried 
to find the relationship between nutritional status (body mass index/BMI) and 
nasopharyngeal cancer patients’ survival rate, but the results are still inconsistent. This 
study aims to find the relationship between nutritional status represented by BMI and 
nasopharyngeal cancer patients’ survival rate. 
Methods: Electronic literature searches were performed in Cochrane®, Scopus®, and 
Pubmed®. MesH term and title/abstracts were screened based on inclusion and exclusion 
criteria before relevant journals were reviewed. 
Result: Two articles were selected based on the eligibility criteria and relevancy to the 
clinical question. In the study of Huang et al., the subject was nasopharyngeal cancer 
patient stage III and IV was included as subject of the study. In the study of Lin et al., 
nasopharyngeal cancer patient with metastases was also included. Patient with higher BMI 
has better survival rate than underweight BMI category. 
Conclusions: Increasing BMI in underweight cancer patients improves nasopharyngeal 
cancer patients’ survival rate. 
Keywords nasopharyngeal cancer, nasopharyngeal neoplasm, body mass index, BMI, survival rate, 
prognosis 
 
 
Clinical Scenario 
 
A 40-years-old male patient came to the outpatient 
clinical nutrition specialist in RSCM National 
Hospital. He was referred from the ear, nose, and 
throat (ENT) specialist for nutritional management. 
He has been suffering from nasopharyngeal cancer 
since last year. He has lost of appetite since 6 months 
ago. He experienced unexplained 15 kg weight-loss 
in one month. The ENT specialist planned to give 
him chemo radiotherapy. In the past 2 months, he 
only ate 3–4 tablespoons of porridge per day.   
Physical examination showed subcutaneous muscle 
loss. Based on his history of weight loss, BMI 
calculation, and physical examination, he was 
categorized as cancer cachexia. The clinical 
nutrition specialist gave medical nutrition therapy to 
increase his intake to overcome malnutrition 
condition. He asked whether improving his 
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nutritional status would increase his chance of 
survival. 
 
Introduction 
 
Head and neck cancer is the seventh leading cancer 
in the world. Head and neck cancer can occur in oral 
cavity, pharynx, and larynx, with squamous cell 
carcinoma as the most common histopathological 
findings. Nasopharyngeal cancer (NPC) is one of the 
most common cancer in South East Asia and North 
Africa Region.1 In Indonesia, NPC is one of the most 
frequent head and neck cancer type (28.4%) with 
prevalence of 6.2/100.000 population. 
Nasopharyngeal cancer frequently happens more in 
male than female.1 
Risk factors of NPC are smoking habit, 
alcohol consumption, history of Epstein-Barr virus 
(EBV) infection, history of human papilloma virus 
infection, radiation exposure, preserved food, and 
genetic factor.2,3 Clinical findings of patients with 
NPC are hoarseness, feeling of foreign body in their 
throat, lump at neck area, and abnormal findings in 
radiology imaging. Diagnosis of NPC is from 
histopathological findings. Management of NPC 
depends on the cancer stage, availability of 
treatment modality, and clinical experts. Treatment 
for NPC can be divided into surgical, non surgical, 
and combination therapy. Non surgical treatment 
consists of chemotherapy and radiotherapy.3 
Nasopharyngeal cancer patients often suffer 
from treatment complications such as normal tissue 
damages. The most common acute treatment 
complication include mucositis and dysphagia, 
meanwhile long term effect appears as xerostomia, 
loss of taste sensation, secondary malignancy, and 
fibrosis on neck region. Other complications are 
nausea and vomiting due to chemotherapy. All of 
these complications can disrupt patient’s food intake 
which result in malnutrition and dehydration.4 
Many studies currently have focused on the 
prognostic factors of NPC patients. Some known 
prognostic factors include cancer stage, EBV DNA 
findings, and nutritional status.5 Compared to other 
methods such as body composition measurement or 
laboratory examination, BMI measurement is an 
easy and inexpensive method to determine a 
patient’s nutritional status.6 Some studies have 
found the relationship between BMI and survival 
rate of NPC patients but the results remain 
inconsistent.7 For that reason, the relationship 
between BMI and the survival rate of` cancer 
patients is an interesting subject as knowing it is 
necessary to determine the appropriate BMI target 
for cancer patients. 
 
Clinical Question 
 
Subjects included in this study are adult patients 
with nasopharyngeal cancer. The factor being 
analyzed is the influence of BMI to patients’ 
prognosis. The outcome of this study is survival rate. 
Therefore, this formulates a clinical question: Can 
BMI affect the survival rate of adult patients with 
nasopharyngeal cancer? 
 
Methods 
 
Article searching 
 
The literature searching was performed using 
advanced searching from three large databases: 
Pubmed®, Cochrane®, and Scopus® on October 9th 
2018 that screened by MesH Term and abstract/title. 
The keywords were “nasopharyngeal cancer”, 
“nasopharyngeal neoplasm”, “body mass index”, 
“BMI”, “survival rate”, and “prognosis”. The result 
of this literature searching was cleaned from 
duplication by EndNote application. After 
narrowing down literatures based on their titles and 
abstracts with the clinical question, the full text 
literatures which met the eligibility criteria were 
critically appraised. 
 
Article selection 
 
Eligibility criteria 
Article selection was based on the inclusion and 
exclusion criteria, which addressed the clinical 
question. The inclusion criteria were: 1) the study 
subjects were diagnosed as nasopharyngeal cancer; 
2) subjects were adult patients (aged ≥18 years old); 
3) subject has the same characteristic; 4) BMI 
measurement was done before patients did 
chemotherapy and radiotherapy; 5) the study design 
was systematic review or cohort 6) study’s outcome 
measure was survival rate or prognosis; and 7) 
publication within the last 5 years. The exclusion 
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criteria were: 1) no available full text and 2) non-
English journal. 
Critical appraisal 
 
Critical appraisal was done using cohort methods 
with BMI as prognostic factor for NPC’s survival 
rate. Every article was assessed by two reviewers for 
its validity, importance, applicability (VIA) using 
standardized criteria for prognostic research critical 
appraisal.8 
 
Results 
 
Based on the inclusion and exclusion criteria, 
journal articles identified were 19 from Pubmed® 
and 22 from Scopus®. (Table 1) 
Those 41 articles were screened for 
duplication using endnote X7. Eleven out of 41 
articles have duplication, thus only 30 articles used 
for the next step. There were only 2 articles that met 
the eligibility criteria, meanwhile 28 articles 
excluded. Among 28 articles excluded, 25 articles 
used prognostic factors other than BMI, 1 article was 
therapeutic study, one article as diagnostic study, 
and 1 article used language other than English 
(Figure 1). 
These articles were retrospective and 
prospective cohort studies. All studies had a level 
evidence of 2. The total sample is adequate to 
represent nasopharyngeal cancer patients. The 
subjects were taken from single cancer center in 
endemic area in China. Study characteristics are 
shown in Table 2. The study by Li W et al. satisfied 
all appraisal criteria. On the other hand, the study by 
Huang PY et al. lacked in one of validity criteria 
(Table 3, 4, and 5). 
 
Discussion 
 
Nutritional status can be assessed by measuring BMI 
or body composition. BMI is one of the prognostic 
factor for NPC. Body composition measurement is 
an accurate method yet expensive, and a specific 
tool must be used. Meanwhile, BMI is the simple 
and inexpensive method.6  
Table 1. Resources and search strategy 
Database Search Strategy Hits 
Pubmed ((((nasopharyngeal cancer[MeSH Terms]) OR nasopharyngeal 
neoplasm[Title/Abstract])) AND (((body mass index[MeSH Terms]) OR "body mass 
index"[Title/Abstract]) OR "BMI"[Title/Abstract])) AND (((survival rate[MeSH 
Terms]) OR "survival rate"[Title/Abstract]) OR prognosis[Title/Abstract]) 
19 
Cochrane 
Library 
#1     ("body mass index"):ti,ab,kw OR ("BMI"):ti,ab,kw in Cochrane Reviews 
(Word variations have been searched) N: 93 
#2    MeSH descriptor: [Body Mass Index] explode all trees N:9240 
#3 #1 OR #2 N:9307 
#4 ("survival rate"):ti,ab,kw OR ("prognosis"):ti,ab,kw in Cochrane Reviews 
(Word variations have been searched) N:230 
#5 MeSH descriptor: [Survival Rate] explode all trees N:9443 
#6 #4 OR #5 N:9661 
#7 #3 AND #6 N:45 
#8 (nasopharyngeal cancer):ti,ab,kw OR (nasopharyngeal neoplasm):ti,ab,kw in 
Cochrane Reviews (Word variations have been searched) N:2 
#9 MeSH descriptor: [Nasopharyngeal Neoplasms] explode all trees N:332 
#10 #8 OR #9 N:332 
#11 #3 AND #6 AND #10 N:0 
0 
Scopus (TITLE-ABS-KEY(nasopharyngeal AND cancer )  OR  TITLE-ABS-
KEY ( nasopharyngeal  AND neoplasm )  AND  TITLE-ABS-KEY ( "body mass 
index" )  OR  TITLE-ABS-KEY ( "BMI" )  AND  TITLE-ABS-
KEY ( survival  AND rate )  OR  TITLE-ABS-
KEY ( prognosis )  AND  LANGUAGE ( english ) )  AND  DOCTYPE ( ar  OR  re )  
AND  PUBYEAR  >  2012  
22 
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Energy Reserve of Hibernation Hypothesis 
explained that adipose tissue in cancer patients act 
as nutrient reserve in times of stress such as in 
patients undergoing cancer treatment. This 
hypothesis explained the possible mechanism of the 
relationship between BMI and cancer survival rate.11 
Li W, et al.8 conducted a retrospective study 
to 819 nasopharyngeal cancer patients (median age 
45 years old and age range 18–78 years old) with 
distant metastases whom being treated between 
1998 and 2007 at Sun Yat - Sen University Cancer 
Center, China. During palliative chemotherapy, 
patients were evaluated by computed tomography or 
magnetic resonance imaging for response every two 
cycles and then every 3 months or the last follow-up 
(June 30, 2014) with OS and PFS as the primary 
outcomes. Result of this research was higher BMI 
patients had a significantly longer overall survival 
compared with underweight patients (HR 0.62; 95% 
CI 0.48–0.81; p<0.001) and normal-weight patients 
(HR 0.72; 95% CI 0.57–0.90). In contrast, PFS rates 
had no association with BMI (p= 0.407).10  
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N: 2 Record excluded 
N: 28 
Reasons: 
• Prognostic factor 
other than BMI: 25 
• Therapeutic study: 1 
• Diagnostic study: 1 
• Not in English: 1 
Full-text articles 
assessed for eligibility 
N: 2 
Full-text articles excluded 
with reason 
N: 0 
Studies included in 
qualitative synthesis 
N: 2 
Scopus 
N: 22 
Figure 1. Flow chart of literature searching 
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 Table 2. Study characteristics 
Articles Study design Population Outcome 
Li W, et al.,  
(2016) 
 
Retrospective 
cohort  
study  
819 patients >18 years with distant metastasis 
NPC. Patients were  
classified into: underweight (n:168),  
normal weight (n:431), and  
overweight/obese (n:220) 
Overall survival (OS) 
rates and  
progression-free  
survival (PFS). 
Huang PY, et  
al., (2013) 
 
Prospective 
cohort  
study  
400 patients with NPC stage III and  
IVa. Patients were divided into: 
underweight (n:41), normal (n:  
184),overweight (n: 83), and obese  
(n: 33) 
Local-regional  
failure-free survival  
(LR-FFS), distant  
failure-free survival  
(D-FFS), FFS, OS 
D-FFS: distant failure-free survival; LR-FFS: local-regional failure-free survival; NPC: nasopharyngeal cancer; OS: overall 
survival; PFS: progression-free survival 
 
Table 3. Validity criteria 
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Result Level of 
Evidence9 
Li W, et  
al10 + + + + + + + + 
A 2 
Huang  
PY, et  
al7 
+ + + - + + + + 
B 2 
A: Higher BMI patients had a significantly higher 5-year OS rates than underweight patients (p<0,001).10 
B: Higher BMI patients had a significantly higher 5-year OS rates, FFS rates, LR-FFS rates and D-FFS rates than 
underweight patients (p=0,001, p=0,014, p=0,045 and p=0,037 respectively)7 
 
Table 4. Relevance criteria 
Articles Similarity Population Similarity Determinant Similarity Outcome 
Li W et al10 + + + 
Huang PY et al7 + + + 
 
Table 5. Importance criteria 
Articles Outcome n Hazard ratio 95% CI 
Li W, 
et al10 
Overall survival (OS) rates and  
progression-free survival (PFS) 
819 Higher BMI compared with 
underweight patients:  
HR 0.62.  
0.48–0.81 
 
Huang  
PY, et  
al7 
5-year OS rates in under,  
normal, overweight, obese  
group: 51%, 68%, 80%, 72%,  
respectively (p=0.001). 
5-year FFS rates in under,  
normal, overweight, obese  
group: 44%, 61%, 68%, 73%,  
respectively (p=0.014) 
400 Higher BMI compared  
with normal-weight 
patients: HR 0.57 
 
0.39–0.84 
BMI: body mass index; CI: confidence interval; FFS: failure-free survival;; OS: overall survival; PFS: progression-free 
survival 
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The prospective cohort study by Huang, et al. was 
conducted at Sun-Yat-sen University Cancer Centre, 
China. Four hundred patients with stage III or IVa 
nasopharyngeal carcinoma were recruited for a 
randomized clinical trial of induction chemotherapy 
combined with radiotherapy or concurrent chemo 
radiotherapy. The mean age was 43 years (range 18–
65 years). Patients with different histopathology 
type and distant metastases were excluded. The 
subjects were collected from August 2002 to April 
2005 and last follow-up was in August 2011. The 
results showed that higher BMI patients had longer 
overall survival rates compared with normal weight 
patients (HR 0.574; 95% CI 0.391–0.845). In a 
multivariate analysis, whether BMI was calculated 
as a categorical variable or as a continuous variable, 
the results showed that BMI was an independent 
factor for the overall survival of loco regionally 
advanced nasopharyngeal carcinoma treated with 
chemoradiotherapy.7 
In the study of Li W, et al.8, there are several 
reasons why higher BMI patients with metastatic 
NPC had a better survival rate. First, higher BMI 
patients are less susceptible to malnutrition and/or 
cachexia than underweight patients with head and 
neck cancer. Malnutrition and cachexia are 
associated with reduced tolerance to cancer 
therapies, impaired immunity, and poor outcomes. 
Second, based on the preliminary data, higher BMI 
group received more cycles of palliative therapy 
after metastasis diagnosis than underweight group. 
Higher BMI group may prolong the patients’ 
tolerance to continuous treatment because they 
could receive more aggressive therapy rather than 
underweight group. However, higher BMI did not 
necessarily improve therapy’s efficacy.8 
Underweight patients in these two studies 
may suffer from an advanced stage of tumor. But, 
the study by Huang PY, et al. did not find significant 
differences between pre-treatment BMI and the NPC 
stage distribution.6 The BMI measurement in this 
study was taken on day 1 of chemotherapy while Li 
W, et al. measured within 14 days. In 14 days, 
patients might experience the therapy’s adverse 
effects such as nausea, vomiting, and decreased 
appetite so the pre-treatment BMI may be different 
if taken in last day.  
Li W, et al. also observed that BMI level was 
still significant in predicting OS after analyzing it 
with age, metastasis onset, bone metastasis, and the 
number of lesions. However, further comprehensive 
studies are required to evaluate the relationship 
between the advanced stage of tumor and patients 
with low BMI.8 
Our patient is 40 years old male with NPC. 
He was categorized as cancer cachexia due to history 
of weight loss, body mass index, and physical 
examination. His age is similar with age 
characteristics in both studies. Researches show that 
the survival rates of higher BMI patients was better 
than underweight patients. In this case, we 
recommend giving the patient continuous medical 
nutrition therapy in order to increase his chance of 
survival. This is important because the prevalence of 
NPC in Indonesia is increasing. To conclude, adult 
NPC patients must have a better nutritional status 
while they received treatment. 
 
Conclusion 
 
BMI is one of independent prognostic factors that 
affect the overall survival of adult NPC patients. 
This scientific evidence can be the basis to 
implement nutritional support. Patients with higher 
BMI compared with underweight patients may have 
a better quality of life and therefore a higher survival 
chance. From this evidence-based case report, we 
conclude that nutritional support should be an 
integrated part of nasopharyngeal cancer’s 
management. The limitation found in this evidence 
based case report is the lack of research regarding 
BMI as a risk factor for NPC. Further studies are 
required so that the clinician will be able to decide 
the best BMI target for NPC patients. 
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